Compare State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR Bloomberg 1-3 Month T-Bill ETF vs CVS Health Corp — how do they compare? State Street SPDR Bloomberg 1-3 Month T-Bill ETF trades at $91.52, while CVS Health Corp trades at $106.03 (market cap $135.12B). The key difference: CVS Health Corp pays a 2.51% dividend while State Street SPDR Bloomberg 1-3 Month T-Bill ETF pays none, and CVS Health Corp is trading nearer its 52-week high, State Street SPDR Bloomberg 1-3 Month T-Bill ETF nearer its low. Which is the better fit depends on your goals.
| BIL | CVS | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $91.77 | $106.18 |
52-Week Low | $91.27 | $58.75 |
Market Cap | — | $135.12B |
Enterprise Value | — | $201.66B |
Dividend Yield | — | 2.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL tracks the performance of short-term U.S. Treasury bills with maturities between 1 and 3 months. It is designed for investors seeking a highly liquid, low-risk vehicle for cash management and capital preservation.
Read more on BIL →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
